- Q1. What is the business of Manipal Health Enterprises Limited ?It is a leading hospital chain operating multi-speciality hospitals offering advanced tertiary and quaternary care services, including cardiology, oncology, and organ transplants across India.
- Q2. Why is the company raising funds via IPO?Manipal Health Enterprises is raising funds via IPO to reduce debt, fund acquisitions like Sahyadri Hospitals, and support expansion of its healthcare network and infrastructure.
- Q3. What is the size of the issue and where will it list?The IPO includes a Fresh Issue of ₹ 8000 Crore and an Offer for Sale (OFS) of ~4.32 Cr Equity shares. It will be listed on NSE and BSE platform.
- Q4. What are the key risks to an investor?Key risks include high capital expenditure, regulatory pricing risks, competition from large hospital chains, and dependence on occupancy rates can impact profitability and returns.
- Q5. What are the potential upsides?Potential upsides include strong brand, large hospital network, rising healthcare demand, and expansion opportunities position the company for long-term growth in India’s underpenetrated healthcare sector.
- Q6. How to apply for the IPO?Investors can apply for the IPO through ASBA via net banking or using UPI through registered stock brokers once the IPO opens for subscription.
Upcoming
Manipal Health Enterprises Limited
0
IPO Score
0
*Score varies on actual price
Manipal Health Enterprises Limited is a leading healthcare service provider engaged in operating and managing multi-speciality hospitals, clinics, and diagnostic centers across India. The company focuses on tertiary and quaternary care services such as cardiology, oncology, neurosciences, and orthopaedics, serving patients through both inpatient and outpatient care.
Manipal Health Enterprises Limited was incorporated in 2010 & currently Mr. Dilip Jose serves as the Managing Director & CEO of the company.
Manipal Health Enterprises Limited filed its DRHP with SEBI on March 23, 2026. The IPO features a fresh issue of ₹ 8000 crore and an Offer for Sale (OFS) of ~ 4.32 Cr equity shares.
It offers Multi-speciality hospital services with focus on tertiary & quaternary care (cardiology, oncology, neurosciences, orthopaedics, renal sciences). Integrated healthcare ecosystem including hospitals, clinics, diagnostics, inpatient & outpatient services, with revenue from patients, insurance, corporates & government schemes.Manipal Health Enterprises Limited Operates ~33+ hospitals network with ~12,000+ beds across India (one of the largest hospital chains). Among top 2 healthcare providers in India by size, indicating strong market presence and reach.
Subscription date to apply for Manipal Health Enterprises Limited is yet to be announced. Price band for the IPO is yet to be declared.
Revenue, PAT, EBITDA
Year |
2025 |
|---|---|
Networth
|
₹ 5865.65 Cr
|
Revenue
|
₹ 8242.25 Cr
|
EBITDA
|
₹ 2247.07 Cr
|
PAT
|
₹ 1081.67 Cr
|
EBITDA Margin
|
~27.26%
|
PAT Margin
|
~ 13.12%
|
Face Value
|
Rs.02 per Equity Share
|
IPO Important Dates
# |
Date |
|---|---|
Open Date
|
TBA
|
Close Date
|
TBA
|
Anchor Investor Bidding
|
TBA
|
Allotment Date
|
TBA
|
Refunds& Demat Credit
|
TBA
|
Tentative Listing Date
|
TBA
|
Use Of Proceeds
Purpose |
Amount |
|---|---|
Borrowing Repayment
|
₹ 5378 Cr
|
Subsidiary Investment
|
₹ 574 Cr
|
-
|
-
|
-
|
-
|
-
|
-
|
General Corporate Purpose
|
Balance
|
Financial Data
# |
2023 |
2024 |
2025 |
|---|---|---|---|
Revenue (₹ Cr)
|
₹ 4,839.6
|
₹ 6,171.6
|
₹ 8,242.3
|
PAT (₹ Cr)
|
₹ 414.2
|
₹ 533.2
|
₹ 1,081.7
|
Asset (₹ Cr)
|
₹ 7,936.8
|
₹ 10,818.8
|
₹ 14,072.1
|
Net Worth (₹ Cr)
|
₹ 3,325.3
|
₹ 4,029.2
|
₹ 5,865.7
|
IPO Grey Market Premium
Date |
IPO Price |
IPO GMP |
Profit Per Lot |
|---|---|---|---|
23-Aug
|
₹ –
|
₹ –
|
₹ –
|
22-Aug
|
₹ –
|
₹ –
|
₹ –
|
21-Aug
|
₹ –
|
₹ –
|
₹ –
|
20-Aug
|
₹ –
|
₹ –
|
₹ –
|
19-Aug
|
₹ –
|
₹ –
|
₹ –
|
Promoters – Pre offer equity (Approx)
Promoters |
% Shares |
|---|---|
Kangto Investments Pte. Ltd.
|
~ 26.45 %
|
Manipal Global Health Services
|
~ 19.68 %
|
Imperius Healthcare Investments Pte. Ltd.
|
~ 17.77 %
|
Kabru Investments Pte. Ltd.
|
~ 5.78 %
|
Dr. Ranjan Ramdas Pai
|
~ 0.18 %
|
-
|
-
|
Lot Size details
Application Type |
Lot Size |
No. of Lot |
No. of Shares |
Investment Amount |
|---|---|---|---|---|
Retail (Min)
|
–
|
1
|
–
|
₹ –
|
Retail (Max)
|
–
|
13
|
–
|
₹ –
|
HNI (Min)
|
–
|
14
|
–
|
₹ –
|
HNI (Max)
|
–
|
66
|
–
|
₹ –
|
Big HNI (Min)
|
–
|
67
|
–
|
₹ –
|
Key Performance Index (KPI)
ROE |
00 |
|---|---|
ROCE
|
00
|
RoNW
|
00
|
Lead / Book Running Lead Managers
Kotak Mahindra Capital Company Limited Axis Capital Limited UBS Securities India Private Limited Goldman Sachs (India) Securities Private Limited Jefferies India Private Limited ,J.P. Morgan India Private Limited, UBS Securities India Private Limited, DBS Bank India Limited
Registrar (RTA)
KFin Technologies Limited
JOIN OUR SOCIAL-MEDIA PLATFORMS TO STAY UPDATED
Checkout more upcoming IPO's
Executive Centre India Limited
Executive Centre India Limited provides premium flexible workspace and serviced office solutions by leasing Grade-A...
Read More
Sahajanand Medical Technologies Limited
Sahajanand Medical Technologies Limited is an R&D-driven medical device manufacturer specializing in advanced cardiovascular devices...
Read More
Lamtuf Limited
Lamtuf Limited is a Hyderabad‑based industrial manufacturer engaged in the production and sale of industrial...
Read More
Silver Consumer Electricals Limited
Silver Consumer Electricals Limited is engaged in the manufacturing of electrical consumer durable products such...
Read More
Steel Infra Solutions Company Limited
Steel Infra Solutions Company Limited is an integrated structural steel solutions provider catering to large-scale...
Read More